Colgate Palmolive (India) Limited vs Gillette India Limited
An objective side-by-side of COLPAL and GILLETTE, both in Personal Care - Multinational: valuation, profitability, growth, balance sheet, ownership and share-price performance. Where one number is clearly better on its own terms (lower P/E, higher ROE), it is shaded. That is a description, not a recommendation.
Prices as of 2026-09-25 close
Latest results: COLPAL Jun 2026 · GILLETTE Jun 2026
At a glance
- Colgate Palmolive (India) Limited is the larger company by market value, about 2.2 times the size of Gillette India Limited.
- On trailing earnings, Gillette India Limited trades at the lower P/E (34.5 against 37.4).
- Colgate Palmolive (India) Limited earns the higher return on equity (85.1% against 70.6%).
- Over three years Gillette India Limited has grown profits faster (31% a year against 8%).
- Over the past year the share prices returned -20.6% (COLPAL) and -31.7% (GILLETTE).
| Metric | Colgate Palmolive COLPAL |
Gillette India GILLETTE |
|---|---|---|
| Size and price | ||
| Market cap | ₹50,475 Cr | ₹23,044 Cr |
| Share price | ₹1,856 | ₹7,072 |
| Valuation | ||
| P/E | 37.44 | 34.47 |
| P/B | 31.87 | 24.33 |
| EV/EBITDA | 26.59 | 23.98 |
| PEG | 4.68 | 1.11 |
| Dividend yield | 2.8% | 1.7% |
| Profitability | ||
| ROE | 85.1% | 70.6% |
| ROCE | 108.0% | 91.0% |
| Operating margin | 30.6% | 30.3% |
| Sales (TTM) | ₹6,204 Cr | ₹3,176 Cr |
| Net profit (TTM) | ₹1,348 Cr | ₹668 Cr |
| Growth | ||
| Latest quarter sales YoY | +11.8% | +10.8% |
| Latest quarter profit YoY | +6.9% | +9.2% |
| Sales CAGR 3Y | +5.0% | +11.0% |
| Profit CAGR 3Y | +8.0% | +31.0% |
| Sales CAGR 5Y | +5.0% | +13.0% |
| Profit CAGR 5Y | +5.0% | +23.0% |
| Financial strength | ||
| Debt/Equity | 0.03 | 0.00 |
| Interest cover | 431.00 | 72.08 |
| Ownership | ||
| Promoter holding | 51.0% | 75.0% |
| Promoter change (4 qtrs) | +0.00 pp | +0.00 pp |
| Price performance | ||
| Return 1M | -0.23% | -4.48% |
| Return 3M | -7.17% | -6.47% |
| Return 1Y | -20.62% | -31.68% |
| Return YTD | -10.59% | -15.43% |
| Technical condition | ||
| Technical score | 51 | 15 |
| RS rating (1-99) | 33.00 | 24.00 |
| % vs 200-DMA | -9.29% | -10.31% |
| RSI (14) | 46.23 | 35.00 |
| % from 52-week high | -21.29% | -31.54% |
